Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques

Autor: José Crecente-Campo, María J. Alonso, Hongzhao Li, Ma Luo, Francis A. Plummer, Mohammad Abul Kashem, Lin Li, Dane Schalk, Lewis R. Liu, Robert W Omange, Nikki Toledo, Binhua Liang, James B. Whitney, Qingsheng Li, Yan Hai, Nancy Schultz-Darken, Tamara G Dacoba, So-Yon Lim, Eva G. Rakasz, Yanmin Wan
Přispěvatelé: Universidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas, Universidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica, University of Manitoba
Rok vydání: 2018
Předmět:
Zdroj: PLoS ONE, Vol 13, Iss 8, p e0202997 (2018)
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
ISSN: 1932-6203
Popis: HIV mutates rapidly and infects CD4+ T cells, especially when they are activated. A vaccine targeting conserved, essential viral elements while limiting CD4+ T cell activation could be effective. Learning from natural immunity observed in a group of highly HIV-1 exposed seronegative Kenyan female sex workers, we are testing a novel candidate HIV vaccine targeting the 12 viral protease cleavage sites (PCSs) (the PCS vaccine), in comparison with a vaccine targeting full-length Gag and Env (the Gag/Env vaccine) in a Mauritian cynomolgus macaque/SIV model. In this study we evaluated these vaccines for induction of mucosal antibodies to SIV immunogens at the female genital tract. Bio-Plex and Western blot analyses of cervicovaginal lavage samples showed that both the PCS and Gag/Env vaccines can elicit mucosal IgG antibody responses to SIV immunogens. Significantly higher increase of anti-PCS antibodies was induced by the PCS vaccine than by the Gag/Env vaccine (p
Databáze: OpenAIRE